Module

Consequences of Failure: Outcomes and Options After Failure of the Initial Antiretroviral Regimen

Source: Managing HIV-Infected Patients With Initial Regimen Failure

Consequences of Failure: Outcomes and Options After Failure of the Initial Antiretroviral Regimen

Program Director: Joseph J. Eron, Jr., MD

Faculty:

Charles B. Hicks, MD
Susanna Naggie, MD

CME CREDIT INFORMATION

Release Date: 10/20/08

Expiration Date: 10/19/09

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Identify common causes of first-line antiretroviral regimen failure
Describe the role of drug resistance assessment in tailoring optimal second-line regimens
Discuss data guiding the choice of second-line regimens for patients failing either NNRTI- or PI-based initial therapy
Recount data from clinical trials investigating agents from new antiretroviral classes in treatment-experienced patients

Topics covered include:

Assessing Antiretroviral Treatment Failure
Determining the Cause of First-Line Regimen Failure
Assessing Antiretroviral Resistance
Choosing a New Antiretroviral Regimen

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.